Italia markets closed

BMY May 2024 40.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,10000,0000 (0,00%)
Alla chiusura: 03:34PM EDT
Schermo intero
Chiusura precedente0,1000
Aperto0,0900
Denaro0,0100
Lettera0,2400
Prezzo d'esercizio40,00
Scadenza2024-05-31
Min-Max giorno0,0900 - 0,1000
Contratto - Min-MaxN/D
Volume9
Open Interest44
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri